MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymthe.2020.03.004

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2020

Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors.

Kaid Carolini, Madi Raquel Azevedo Dos Santos, Astray Renato, Goulart Ernesto, Caires-Junior Luiz Carlos, Mitsugi Thiago Giove, Moreno Ana Carolina Ramos, Castro-Amarante Maria Fernanda, Pereira Lennon Ramos, Porchia Bruna Felício Milazzotto Maldonado, de Andrade Thais Oliveira, Landini Vivian, Sanches Daniel Soares, Pires Carolina Gonçalves, Tanioka Rubens Koji Oliveira, Pereira Marcia C L, Barbosa Igor Neves, Massoco Cristina O, Ferreira Luís Carlos de Souza, Okamoto Oswaldo Keith, Zatz Mayana

Клинический случайСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Malignant brain tumors are among the most aggressive cancers with poor prognosis and no effective treatment. Recently, we reported the oncolytic potential of Zika virus infecting and destroying the human central nervous system (CNS) tumors in vitro and in immunodeficient mice model. However, translating this approach to humans requires pre-clinical trials in another immunocompetent animal model. Here, we analyzed the safety of Brazilian Zika virus (ZIKVBR) intrathecal injections in three dogs bearing spontaneous CNS tumors aiming an anti-tumoral therapy. We further assessed some aspects of the innate immune and inflammatory response that triggers the anti-tumoral response observed during the ZIKVBR administration in vivo and in vitro. For the first time, we showed that there were no negative clinical side effects following ZIKVBR CNS injections in dogs, confirming the safety of the procedure. Furthermore, the intrathecal ZIKVBR injections reduced tumor size in immunocompetent dogs bearing spontaneous intracranial tumors, improved their neurological clinical symptoms significantly, and extended their survival by inducing the destruction specifically of tumor cells, sparing normal neurons, and activating an immune response. These results open new perspectives for upcoming virotherapy using ZIKV to destroy and induce an anti-tumoral immune response in CNS tumors for which there are currently no effective treatments.

Для цитирования: Kaid Carolini, Madi Raquel Azevedo Dos Santos, Astray Renato, Goulart Ernesto, Caires-Junior Luiz Carlos, Mitsugi Thiago Giove, Moreno Ana Carolina Ramos, Castro-Amarante Maria Fernanda, Pereira Lennon Ramos, Porchia Bruna Felício Milazzotto Maldonado, de Andrade Thais Oliveira, Landini Vivian, Sanches Daniel Soares, Pires Carolina Gonçalves, Tanioka Rubens Koji Oliveira, Pereira Marcia C L, Barbosa Igor Neves, Massoco Cristina O, Ferreira Luís Carlos de Souza, Okamoto Oswaldo Keith, Zatz Mayana. Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors.. Molecular therapy : the journal of the American Society of Gene Therapy. 2020. DOI: 10.1016/j.ymthe.2020.03.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.